Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
Online ISSN : 1882-8272
Print ISSN : 0388-1601
ISSN-L : 0388-1601
Forum
Current and Issues Status of Ethics Review of Multi-center Research Projects: From the Viewpoint of the Secretariat of the Central Ethics Review Committee
Ryota KITAOTakuya WATANABEShinji KOSUGI
Author information
JOURNAL FREE ACCESS
Supplementary material

2022 Volume 53 Issue 5 Pages 177-188

Details
Abstract

The Japanese research ethics guidelines titled, “Ethical Guidelines for Medical and Biological Research Involving Human Subjects” regulate for collective review. Research and medical institutions now employ internal ethical review systems to conduct reviews. At Kyoto University, the graduate school and faculty of medicine of the ethics committee office has utilized a central collective review system (central REC system) since the establishment of the previous guidelines. The present study details the current status of the central review system and its issues and their potential solutions, based on practical experience of the first author (Kitao) at Kyoto University ethics committee office before and after the implementation of the current guidelines.

The transition to the new research ethics guidelines eliminates the intervention of institutional authorities who are not directly involved in the review process, but further burdens principal investigators, who are now required to collect and submit the confirmation of institutional requirements of collaborating institutions.

The distinct features of the future review system, from the perspective of the Ethics Review Committee Secretariat, are described below.

(1)Changing the review procedure according to the type of research.

(2)Strengthening the research secretariat.

(3)Clarifying and distinguishing the roles of the head of the institution and the Ethical Review Committee.

In future, ethical review procedures should also be evaluated to ensure the true ethicality of clinical research, where researchers are not subject to arbitrary procedures and can focus on the safety and due respect of the research participants.

Content from these authors
© 2022 The Japanese Society of Clinical Pharmacology and Therapeutics
Previous article Next article
feedback
Top